Lower GI: Anal cancer salvage and response assessment
Free question published 16 September 2026
A 59-year-old man treated with definitive mitomycin and 5-fluorouracil chemoradiotherapy for a T2 N0 anal squamous cell carcinoma is reviewed in clinic. At the planned assessment there is a persistent firm nodule at the primary site, and biopsy at 26 weeks confirms residual viable squamous carcinoma without distant metastases. What is the most appropriate management?
- ASalvage abdominoperineal resection
- BPalliative best supportive care only
- CContinued surveillance, as response can occur up to one year after chemoradiotherapy
- DMaintenance cisplatin and 5-fluorouracil chemotherapy
- EA further course of the same chemoradiotherapy to the same dose
Why A is correct
Definitive chemoradiotherapy with mitomycin and 5-fluorouracil is the organ-preserving standard of care for anal squamous cell carcinoma, with surgery reserved for failure. Biopsy-proven persistent disease at 26 weeks represents local failure, and salvage abdominoperineal resection is the mainstay of treatment for locoregional failure after chemoradiation.
And why the others are not
- BIncorrect. With localised, non-metastatic persistent disease, curative-intent salvage surgery is appropriate rather than best supportive care alone.
- CIncorrect. Although some responses occur late, biopsy-confirmed persistent viable tumour at 26 weeks is local failure requiring salvage surgery, not further watching.
- DIncorrect. Maintenance chemotherapy was shown ineffective in ACT II and does not treat established residual disease.
- EIncorrect. Re-irradiation to full dose is not standard for persistent disease and carries prohibitive toxicity; surgery is indicated.
Source Salvage abdominoperineal resection after chemoradiation for anal squamous cell carcinoma — Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with Chemoradiation. J Clin Med. 2024 (PMC11050212).
More free lower gi questions
- Lower GI: Anal cancer definitive chemoradiotherapy · 05 September 2026
- Lower GI: Total neoadjuvant therapy (FOLFIRINOX) · 25 August 2026
- Lower GI: Preoperative versus postoperative chemoradiotherapy · 14 August 2026
Sitting in February? Follow the twenty-week plan.
2,500+ cited questions like this one are waiting in the vault.
See plans and pricing